Abstract
A rare case of Vogt-Koyanagi-Harada disease associated with ribavirin and interferon-alpha treatment for chronic hepatitis C infection is presented. The potential role of interferon and/or ribavirin therapy is discussed. Physicians should be aware of the association between interferon-alpha and ribavirin use for hepatitis C infection and the development of Harada's disease. Close monitoring of such patients for ocular side effects is necessary.
MeSH terms
-
Adrenal Cortex Hormones / administration & dosage
-
Adult
-
Antiviral Agents / adverse effects*
-
Antiviral Agents / therapeutic use
-
Female
-
Fluorescein Angiography
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Interferon-alpha / adverse effects*
-
Interferon-alpha / therapeutic use
-
Retinal Detachment / chemically induced
-
Retinal Detachment / diagnosis
-
Retinal Detachment / pathology
-
Ribavirin / adverse effects*
-
Ribavirin / therapeutic use
-
Treatment Outcome
-
Uveomeningoencephalitic Syndrome / chemically induced*
-
Uveomeningoencephalitic Syndrome / drug therapy
Substances
-
Adrenal Cortex Hormones
-
Antiviral Agents
-
Interferon-alpha
-
Ribavirin